Cargando…
Iloprost in COVID-19: The Rationale of Therapeutic Benefit
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102696/ https://www.ncbi.nlm.nih.gov/pubmed/33969013 http://dx.doi.org/10.3389/fcvm.2021.649499 |
| _version_ | 1783689156229070848 |
|---|---|
| author | Faggioli, Paola Maria Mumoli, Nicola Mazzone, Antonino |
| author_facet | Faggioli, Paola Maria Mumoli, Nicola Mazzone, Antonino |
| author_sort | Faggioli, Paola Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8102696 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81026962021-05-08 Iloprost in COVID-19: The Rationale of Therapeutic Benefit Faggioli, Paola Maria Mumoli, Nicola Mazzone, Antonino Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2021-04-23 /pmc/articles/PMC8102696/ /pubmed/33969013 http://dx.doi.org/10.3389/fcvm.2021.649499 Text en Copyright © 2021 Faggioli, Mumoli and Mazzone. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cardiovascular Medicine Faggioli, Paola Maria Mumoli, Nicola Mazzone, Antonino Iloprost in COVID-19: The Rationale of Therapeutic Benefit |
| title | Iloprost in COVID-19: The Rationale of Therapeutic Benefit |
| title_full | Iloprost in COVID-19: The Rationale of Therapeutic Benefit |
| title_fullStr | Iloprost in COVID-19: The Rationale of Therapeutic Benefit |
| title_full_unstemmed | Iloprost in COVID-19: The Rationale of Therapeutic Benefit |
| title_short | Iloprost in COVID-19: The Rationale of Therapeutic Benefit |
| title_sort | iloprost in covid-19: the rationale of therapeutic benefit |
| topic | Cardiovascular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102696/ https://www.ncbi.nlm.nih.gov/pubmed/33969013 http://dx.doi.org/10.3389/fcvm.2021.649499 |
| work_keys_str_mv | AT faggiolipaolamaria iloprostincovid19therationaleoftherapeuticbenefit AT mumolinicola iloprostincovid19therationaleoftherapeuticbenefit AT mazzoneantonino iloprostincovid19therationaleoftherapeuticbenefit |